Featured Story | By Annalee Armstrong With a legacy to build on, Jaguar Gene Therapy picks up big pharma heavyweight Eli Lilly in a series B funding round for three early-stage gene therapy programs. read more |
| |
|---|
|
Top Stories By Amirah Al Idrus James Chung, a longtime Amgen executive who led global clinical development for autoimmune drug Enbrel, has a new gig. He joins Kyverna Therapeutics as chief medical officer as the company sets its sights on the clinic. Chung was most recently head of inflammation and neuroscience in Amgen’s global medical organization and global development leader for Enbrel. read more By Eric Sagonowsky After drug regulators on both sides of the Atlantic revealed safety probes into Johnson & Johnson’s COVID-19 vaccine, U.S. officials have called for an immediate pause to the rollout. read more Sponsored By: MyData-TRUST 34.4% of worldwide data breaches come from the healthcare sector. Data Protection is no longer just a compliance issue, but a strategic topic. MyData-TRUST was created to support the sector. read more By Annalee Armstrong Theseus Pharmaceuticals, led by a team of ex-Ariad executives, will target treatment-resistant cancers after emerging from stealth mode with $100 million in Series B funding. read more By Ben Adams Recursion Pharmaceuticals has set terms for a major $306 million IPO as the artificial intelligence biotech eyes a $3 billion valuation. read more By Andrea Park Microsoft has its head in the clouds—the Microsoft Cloud for Healthcare, that is, which will soon get a major boost from the tech giant’s acquisition of Nuance Communications. read more By Nick Paul Taylor Repertoire Immune Medicines has raised $189 million to advance anti-cancer T-cell therapies through the clinic while expanding its immune response drug discovery platform. read more By Nick Paul Taylor Tillman Gerngross’ Adagio Therapeutics has begun recruitment in a clinical trial of anti-SARS-CoV-2 antibody ADG20. The study is assessing the effect of a single dose of ADG20 on patients with mild to moderate COVID-19 and a high risk of disease progression. read more |  | Clinical trials are more complex than ever, and you need a central laboratory who can keep pace with your evolving needs. LabConnect is the industry leader when it comes to innovative support services for today’s analytically and logistically complex advanced therapy trials. Contact us today. |
Resources Sponsored By: August Bioservices How has COVID-19 impacted CRO/CDMO customer (dis)satisfaction and outsourcing decisions for pharma and biotech companies in 2021 and beyond? Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored by: PerkinElmer Informatics Discover the benefits of a cloud-native ELN that delivers better performance, security, connectivity, total cost of ownership PLUS sub-second search results through even the largest data volumes. Sponsored By: OCT Clinical Find out why more than 400 clinical trials annually are initiated in Russia by US and EU pharma in the free annual report by OCT Clinical. Sponsored by: PulsePoint Access this guide for the latest insights into how marketers can use data, technology, and personalized messaging to build vaccine confidence and drive successful immunization efforts. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: TAC Roche has inked a $1.8 billion, all-cash deal for GenMark Diagnostics, to acquire its molecular tests designed to screen patient samples for multiple infections simultaneously. Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: BC Platforms Those wishing to unlock RWD’s true value must have access to a variety of data sources/types and the technological capabilities to use the data to uncover meaningful insights. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: Catalent Autologous cell therapies have seen propelled growth since 2017, with the spotlight on the first FDA approval of a chimeric antigen receptor (CAR) T cell immunotherapy, Kymriah® (tisagenlecleucel), for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. | 
